About the Project
DNA damage signalling plays an important role in cancer as impaired DNA repair enables cancer cells to accumulate oncogenic DNA lesions. Molecular profiling of PRISM samples indeed showed frequent aberrations in DNA repair genes such as CHEK1 and -2, ATM, BRCA1, MSH6 and TP53 as well as the presence of mutational signatures indicative for BRCA-deficiency or impaired mismatch repair. The current study aims to unravel the DNA damage signalling landscape of paediatric cancers and to investigate strategies to exploit this knowledge to develop personalised therapies. This will for example be done by high-throughput in vitro testing of a DNA damage/repair drug library on unique patient-derived model systems. As treatment with single agents has been proven to be insufficient for complete cure in most cases, most promising drug candidates will be further studied in vitro and in vivo to identify combination strategies overcoming tumour resistance to single agents. Results are aimed at guiding future clinical trials for paediatric cancer treatment.
All students at the Institute must fulfil the requirements for enrolment at UNSW to undertake their PhD with us as well as obtain a scholarship that will cover both your living expenses and tuition fees. Scholarship and entry requirements will be provided on request.
Why not add a message here
Based on your current searches we recommend the following search filters.
Based on your current search criteria we thought you might be interested in these.